المؤلفون: STRADELLA, AGOSTINA, Johnson, Melissa L., GOEL, SANJAY, Park, Haeseong, Saavedra, Omar, Lakhani, Nehal, Arkenau, Hendrik-Tobias

المساهمون: Institut Català de la Salut, Stradella A Institut Català d'Oncologia–Hospital Duran I Reynals, L'Hospitalet de Llobregat, Catalunya, Spain. Johnson M Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee, USA. Goel S Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Park H Washington University School of Medicine, St. Louis, Missouri, USA. Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Lakhani N START Midwest, Grand Rapids, Michigan, USA. Arkenau HT Sarah Cannon Research Institute, UCL Cancer Institute, University College London, London, UK. Saavedra O Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Càncer - Tractament, Avaluació de resultats (Assistència sanitària), Quimioteràpia combinada, Medicaments - Administració, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, DISEASES::Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, AND EQUIPMENT::Therapeutics::Drug Therapy::Drug Administration Schedule, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, ENFERMEDADES::neoplasias, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::pauta de administración medicamentosa

وصف الملف: application/pdf

Relation: Cancer Medicine;13(13); https://doi.org/10.1002/cam4.7385; Stradella A, Johnson M, Goel S, Park H, Lakhani N, Arkenau HT, et al. Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors. Cancer Med. 2024 Jul;13(13):e7385.; https://hdl.handle.net/11351/11694

الاتاحة: https://hdl.handle.net/11351/11694
https://doi.org/10.1002/cam4.7385

المؤلفون: García-González, Martín J, Mora-Martín, Manuel de, López-Fernández, Silvia, López-Díaz, Javier, Martínez-Sellés, Manuel, Romero-García, José, Cordero, Marco, Lara-Padrón, Antonio, Marrero-Rodríguez, Francisco, García-Saiz, M. del Mar, Aldea-Perona, Ana

المساهمون: The LAICA study investigators, García-González,MJ Department of Cardiology, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Sta. Cruz de Tenerife, Spain. Mora-Martín,M de Department of Cardiology, Hospital Regional Carlos Haya, Málaga, Spain. López-Fernandez,S Department of Cardiology, Hospital Virgen de la Nieves, Granada, Spain. López-Díaz,J Department of Cardiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. Martínez-Sellés,M Department of Cardiology, Hospital General Universitario Gregorio Marañón, Universidad Europea, Madrid, Spain. Romero-García,J Department of Cardiology, Fundación Jiménez Díaz, Madrid, Spain. García-Saiz,M del M Department of Clinical Pharmacology, Hospital Universitario de Canarias, La Laguna, Sta. Cruz de Tenerife, Spain. Aldea-Perona,A Clinical Trials Unit, Biomedical Research Unit, Fundación Rafael Clavijo para la Investigación Biomédica, Hospital Universitario de Canarias, La Laguna, Sta. Cruz de Tenerife, Spain., Department of Pharmacy and Health Products. Ministry of Health, Social Services and Equality, Government of Spain 2009. (TRA-058). Department of Health. Canary Islands Government. Fundación Canaria de Investigación y Salud (FUNCIS) 2010. Additional research unrestricted grant from ORION PHARMA Laboratory

مصطلحات موضوعية: Advanced heart failure, Levosimendan, Efficacy, Safety, Repeated administration, Outpatients, Insuficiencia cardíaca, Resultado del tratamiento, Pauta de administración medicamentosa, Pacientes Ambulatorios, Morbilidad, Mortalidad, Hospitalización, Cardiotónicos, Estudios multicéntricos como asunto, Estudios prospectivos, Ensayos clínicos controlados como asunto, Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Heart Failure, Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Medical Subject Headings::Named Groups::Persons::Patients::Outpatients, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Hospitalization, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Cardiovascular Agents::Cardiotonic Agents, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Clinical Trials as Topic::Multicenter Studies as Topic, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies

وصف الملف: application/pdf

Relation: http://link.springer.com/article/10.1007%2Fs10557-013-6476-7; García-González MJ, de Mora-Martín M, López-Fernández S, López-Díaz J, Martínez-Sellés M, Romero-García J, et al. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study. Cardiovasc Drugs Ther. 2013; 27(6):573-9; http://hdl.handle.net/10668/1538; PMC3830203

الاتاحة: http://hdl.handle.net/10668/1538
https://doi.org/10.1007/s10557-013-6476-7

المؤلفون: Martínez-Santana, Virginia, González-Sarmiento, E, Calleja-Hernández, MA, Sánchez-Sánchez, T

المساهمون: Martínez-Santana,V, Sánchez-Sánchez,T Pharmacy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. González-Sarmiento,E Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. Sánchez-Sánchez,T Pharmacy Department, Hospital Universitario Virgen de las Nieves de Granada, Granada, Spain.

مصطلحات موضوعية: Rheumatoid arthritis, Biologic agents, Tumor necrosis factor, Drug administration schedule, Artritis Reumatoide, Receptores del Factor de Necrosis Tumoral, Agentes Biológicos, Esquema de Medicación, Antirreumáticos, Medical Subject Headings::Diseases::Musculoskeletal Diseases::Rheumatic Diseases::Arthritis, Rheumatoid, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic::Receptors, Cytokine::Receptors, Medical Subject Headings::Chemicals and Drugs::Complex Mixtures::Biological Agents, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antirheumatic Agents

وصف الملف: application/pdf

Relation: http://www.dovepress.com/comparison-of-drug-survival-rates-for-tumor-necrosis-factor-antagonist-peer-reviewed-article-PPA; Martínez-Santana V, González-Sarmiento E, Calleja-Hernández M, Sánchez-Sánchez T. Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis. Patient Prefer Adherence. 2013; 7:719-27; 1177-889X (Online); http://hdl.handle.net/10668/1401; PMC3764953

الاتاحة: http://hdl.handle.net/10668/1401
https://doi.org/10.2147/PPA.S47453

المؤلفون: Kalincik, Tomas, Spelman, Timothy, Trojano, Maria, Duquette, Pierre, Izquierdo, Guillermo, Grammond, Pierre, Lugaresi, Alessandra, Hupperts, Raymond, Cristiano, Edgardo, Van Pesch, Vincent, Grand'Maison, Francois, La Spitaleri, Daniele, Rio, Maria Edite, Flechter, Sholmo, Oreja-Guevara, Celia, Giuliani, Giorgio, Savino, Aldo, Amato, Maria Pia, Petersen, Thor, Fernandez-Bolanos, Ricardo, Bergamaschi, Roberto, Iuliano, Gerardo, Boz, Cavit, Lechner-Scott, Jeannette, Deri, Norma, Gray, Orla, Verheul, Freek, Fiol, Marcela, Barnett, Michael, van Munster, Erik, Santiago, Vetere, Moore, Fraser, Slee, Mark, Saladino, Maria Laura, Alroughani, Raed, Shaw, Cameron, Kasa, Krisztian, Petkovska-Boskova, Tatjana, den Braber-Moerland, Leontien, Chapman, Joab, Skromne, Eli, Herbert, Joseph, Poehlau, Dieter, Needham, Merrilee, Bacile Bacile, Elizabeth Alejandra, Arruda, Walter Oleschko, Paine, Mark, Singhal, Bhim, Vucic, Steve, Cabrera-Gomez, Jose Antonio, Butzkueven, Helmut

المساهمون: The MSBase Study Group, Karkincic,T, Butzkueven,H Departments of Medicine and Neurology, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia. Spelman,T Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia. Trojano,M Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy. Duquette,P Hòpital Notre Dame, Montreal, Canada. Izquierdo,G Hospital Universitario Virgen Macarena, Sevilla, Spain. Grammond,P Hotel-Dieu de Levis, Quebec, Canada. Lugaresi,A MS Center, Department of Neuroscience and Imaging, University ‘G. d’Annunzio’, Chieti, Italy. Hupperts,R Maaslandziekenhuis, Sittard, The Netherlands. Cristiano,E Hospital Italiano, Buenos Aires, Argentina. Van Pesch,V Cliniques Universitaires Saint-Luc, Brussels, Belgium. Grand´Maison,F Neuro Rive-Sud, Hòpital Charles LeMoyne, Quebec, Canada. La Spitaleri,D AORN San Giuseppe Moscati, Avellino, Italy. Rio,ME Hospital S. Joao, Porto, Portugal. Flechter,S Assaf Harofeh Medical Center, Beer-Yaakov, Israel. Oreja-Guevera,C University Hospital San Carlos, IdISSC, Madrid, Spain. Giuliani,G Ospedale di Macerata, Macerata, Italy. Savino,A Consultorio Privado, Buenos Aires, Argentina. Amato,MP Department NEUROFARBA, Section of Neurology, University of Florence, Florence, Italy. Petersen,T Kommunehospitalet, Aarhus C, Denmark. Fernandez-Bolanos,R Hospital Universitario Virgen de Valme, Seville, Spain. Bergamaschi,R Neurological Institute IRCCS Mondino, Pavia, Italy. Iuliano,G Ospedali Riuniti di Salerno, Salerno, Italy. Boz,C Karadeniz Technical University, Trabzon, Turkey. Lechner-Scott,J John Hunter Hospital, Newcastle, Australia. Deri,N Hospital Fernandez, Buenos Aires, Argentina. Gray,O Craigavon Area Hospital, Portadown, United Kingdom. Verheul,F Groen Hart Ziekenhuis, Gouda, The Netherlands. Fiol,M FLENI, Buenos Aires, Argentina. Barnett,M Brain and Mind Research Institute, Sydney, Australia. van Munster,E Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands. Santiago,V HIGA Gral, San Martin La Plata, Argentina. Moore,F Jewish General Hospital, McGill University, Montreal, Canada. Slee,M Flinders University and Medical Centre, Adelaide, Australia. Saladino,ML INEBA, Buenos Aires, Argentina. Alroughani,R Amiri Hospital, Kuwait City, Kuwait. Shaw,C Geelong Hospital, Geelong, Australia. Kasa,K Jahn Ferenc Teaching Hospital, Budapest, Hungary. Petkovska-Boskova,T Clinic of Neurology Clinical Center, Skopje, Macedonia. den Braber-Moerland,L Francicus Ziekenhuis, Roosendaal, The Netherlands. Chapman,J Sheba Medical Center, Tel Hashomer, Israel. Skromne,E Hospital Angeles Mexico City, Lomas, Mexico. Herbert,J New York University Hospital for Joint Diseases, New York, New York, United States of America. Poehlau,D Multiple Sclerosis Centre Kamillus-Klinik, Asbach, Germany. Needham,M Royal North Shore Hospital, Sydney, Australi. Bacile Bacile,EA Instituto de Neurociencias Cordoba, Cordoba, Argentin. Arruda,WO Hospital Ecoville, Curitiba, Brazil. Paine, M St Vincent’s Hospital, Melbourne, Australia. Sighal,B Bombay Hospital Institute of Medical Sciences, Mumbai, India. Vucic,S Westmead Hospital, Sydney, Australia. Cabrera-Gomez,JA Centro Internacional de Restauracion Neurologica, Havana, Cuba. Butzkueven,H Department of Neurology, Box Hill Hospital and Monash University, Melbourne, Australia.

مصطلحات موضوعية: Interferón beta, Relación dosis-respuesta a droga, Inyecciones subcutáneas, Funciones de verosimilitud, Esclerosis múltiple, Espectroscopía de resonancia magnética, Reproducibilidad de los resultados, Resultado del tratamiento, Privación del tratamiento, Adulto, Cumplimiento y adherencia al tratamiento, Medical Subject Headings::Disciplines and Occupations::Social Sciences::Demography, Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Dose-Response Relationship, Drug, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Routes::Injections::Injections, Subcutaneous, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Interferons::Interferon Type I::Interferon-beta, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Kaplan-Meier Estimate, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Likelihood Functions, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Magnetic Resonance Imaging, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Health Behavior::Patient Compliance::Medication Adherence, Medical Subject Headings::Diseases::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases

وصف الملف: application/pdf

Relation: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063480#abstract0; Kalincik T, Spelman T, Trojano M, Duquette P, Izquierdo G, Grammond P, et al. Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis. PLoS ONE. 2013; 8(5):e63480; http://hdl.handle.net/10668/2930; PMC3660604

الاتاحة: http://hdl.handle.net/10668/2930
https://doi.org/10.1371/journal.pone.0063480

المؤلفون: Machado, Carmen, Ríos-Villegas, María José, Gálvez-Acebal, Juan, Domínguez-Castellano, Angel, Fernández-Cuenca, Felipe, Palomo, Virginia, Muniain, Miguel Angel, Rodríguez-Baño, Jesús

المساهمون: Machado,C, Ríos-Villegas,MJ, Gálvez-Acebal,J, Domínguez-Castellano,A, Fernández-Cuenca,F, Palomo,V, Muniain,MA, Rodríguez-Baño,J Infectious Diseases Unit, Hospital Universitario Virgen Macarena. Seville, Spain. Ríos-Villegas,MJ, Rodríguez-Baño,J Departament of Medicine, University of Seville, Seville, Spain., The Andalusian Public Foundation for the management of Research in Health of Seville (FISEVI). The Ministry of Science and Innovation, Institute Carlos III of Health - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008).

مصطلحات موضوعية: HIV-1, Antiretroviral therapy, Treatment interruption, Outcome, Cohort study, Fármacos anti-VIH, Tratamiento antirretrovírico de gran actividad, Pauta de administración medicamentosa, Infecciones por VIH, Estudios retrospectivos, Resultado del tratamiento, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination::Antiretroviral Therapy, Highly Active, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult

وصف الملف: application/pdf

Relation: http://www.biomedcentral.com/1756-0500/5/578/abstract; Machado C, Ríos-Villegas MJ, Gálvez-Acebal J, Domínguez-Castellano A, Fernández-Cuenca F, Palomo V, et al. Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study. BMC Res Notes. 2012; 5:578; http://hdl.handle.net/10668/1571; PMC3532099

الاتاحة: http://hdl.handle.net/10668/1571
https://doi.org/10.1186/1756-0500-5-578

المؤلفون: Navarro-Sarabia, Federico, Ruiz-Montesinos, Dolores, Hernandez, Blanca, Navarro-Compán, Victoria, Marsal, Sara, Barcelo, Mireia, Perez-Pampín, Eva, Gómez-Reino, Juan J

المساهمون: Navarro-Sarabia,F, Ruiz-Montesinos,D, Hernandez,B, Navarro-Compán,V Rheumatology Service, Hospital Universitario Virgen Macarena, Sevilla, Spain. Marsal,S, Barcelo,M Rheumatology Service, Hospital Universitario Vall d'Hebron, Barcelona, Spain. Perez-Pampín,E, Gómez-Reino,JJ Rheumatology Service, Hospital Clínico de Santiago and Department of Medicine, USC, Santiago, Spain., The study was partially funded by a grant of BMS, Spain, and by RETICS Program,RD08/0075 (RIER) from the Instituto de Salud Carlos III (ISCIII),within the VI PN de I+D+I 2008–2011.

مصطلحات موضوعية: Tumor necrosis factor-alpha, Antirreumáticos, Artritis reumatoide, Bases de datos como asunto, Esquema de medicación, Valor predictivo de las pruebas, Cuestionarios, Insuficiencia del tratamiento, Factor de necrosis tumoral alfa, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antirheumatic Agents, Medical Subject Headings::Diseases::Musculoskeletal Diseases::Joint Diseases::Arthritis::Arthritis, Rheumatoid, Medical Subject Headings::Information Science::Information Science::Information Storage and Retrieval::Databases as Topic, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Sensitivity and Specificity::Predictive Value of Tests, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies, Medical Subject Headings::Information Science::Information Science::Data Collection::Questionnaires, Medical Subject Headings::Geographicals::Geographic Locations::Europe::Spain, Medical Subject Headings::Phenomena and Processes::Physical Phenomena::Time::Time Factors, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome::Treatment Failure, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Monokines::Tumor Necrosis Factor-alpha, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult

وصف الملف: application/pdf

Relation: http://www.biomedcentral.com/1471-2474/10/91/abstract; Navarro-Sarabia F, Ruiz-Montesinos D, Hernandez B, Navarro-Compán V, Marsal S, Barcelo M, et al. DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists. BMC Musculoskelet Disord; 2009 10:91; http://hdl.handle.net/10668/1693; PMC2724400

الاتاحة: http://hdl.handle.net/10668/1693
https://doi.org/10.1186/1471-2474-10-91

المؤلفون: Garnacho-Montero, Jose, Aldabo-Pallas, Teresa, Garnacho-Montero, Carmen, Cayuela, Aurelio, Jiménez, Rocio, Barroso, Sonia, Ortiz-Leyba, Carlos

المساهمون: Garnacho-Montero,J, Aldabo-Pallas,T, Jiménez,R, Barroso,S, Ortiz-Leyba,C Intensive Care Unit, Hospital Universitatrio Virgen del Rocio, Seviilla, Spain. Garnacho-Montero,C Institute for Environmental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Cayuela,A Supportive Research Unit, Hospital Universitario Virgen del Rocio, Sevialla, Spain., This research was supported by the Grant (35/01) of the Regional Government of Andalucia.

مصطلحات موضوعية: Antibacterianos, Esquema de Medicación, Mortalidad Hospitalaria, Interleucina-10, Linfotoxina-alfa, Polimorfismo Genético, Sepsis, Factores de Tiempo, Resultado del Tratamiento, Factor de Necrosis Tumoral alfa, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Hospital Mortality, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Interleukins::Interleukin-10, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Lymphokines::Lymphotoxin-alpha, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Polymorphism, Genetic, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies, Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Sepsis, Medical Subject Headings::Phenomena and Processes::Physical Phenomena::Time::Time Factors, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Tumor Necrosis Factors, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged

وصف الملف: application/pdf

Relation: http://ccforum.com/content/10/4/R111/abstract; Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C, Cayuela A, Jiménez R, Barroso S, et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care. 2006; 10(4):R111; http://hdl.handle.net/10668/1688; PMC1751000

الاتاحة: http://hdl.handle.net/10668/1688
https://doi.org/10.1186/cc4995

المؤلفون: García-Carbonero, Rocío, Mayordomo, Jose Ignacio, Tornamira, María V, López-Brea, Marta, Rueda Domínguez, Antonio, Guillém, Vicente, Arcediano, Alberto, Yubero, Alfonso, Ribera, Fernando, Gómez, Carlos, Trés, Alejandro, Pérez-Gracia, José L, Lumbreras, Carlos, Hornedo, Javier, Cortés-Funes, Hernan, Paz-Ares, Luis

المساهمون: García-Carbonero,R, Tornamira,MV, Arcediano,A, Gómez,C, Pérez-Gracia,JL, Hornedo,J, Cortés-Funes,H, Paz-Ares,L Division of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. Mayordomo,JI, Yubero,A, Trés,A Division of Medical Oncology, Hospital Clínico, Zaragoza, Spain. López-Brea,M, Rivera,F Division of Medical Oncology, Hospital M. Valdecilla, Santander, Spain. Rueda Domínguez,A Division of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. Guillém,V Division of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain. Lumbreras,C Division of Infectious Diseases, Hospital Universitario Doce de Octubre, Madrid, Spain.

مصطلحات موضوعية: Antibacterianos, Protocolos de Quimioterapia Combinada Antineoplásica, Análisis Costo-Beneficio, Esquema de Medicación, Fiebre, Factor Estimulante de Colonias de Granulocitos, Tiempo de Internación, Neoplasias, España, Modelos de Riesgos Proporcionales, Análisis de Supervivencia, Factores de Tiempo, Resultado del Tratamiento, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols, Medical Subject Headings::Health Care::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Body Temperature Changes::Fever, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Hematopoietic Cell Growth Factors::Colony-Stimulating Factors::Granulocyte Colony-Stimulating Factor, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Services::Patient Care::Hospitalization::Length of Stay, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged

وصف الملف: application/pdf

Relation: http://jnci.oxfordjournals.org/content/93/1/31.long; García-Carbonero R, Mayordomo JL, Tornamira MV, López-Brea M, Rueda Domínguez A, Guillém V, et al. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. J. Natl. Cancer Inst. 2001; 93(1):31-8; http://hdl.handle.net/10668/741

الاتاحة: http://hdl.handle.net/10668/741
https://doi.org/10.1093/jnci/93.1.31

المؤلفون: Miguel, Martín, Alvaro, Rodríguez-Lescure, Amparo, Ruiz, Emilio, Alba, Lourdes, Calvo, Manuel, Ruiz-Borrego, Blanca, Munárriz, César A, Rodríguez, Carmen, Crespo, Enrique, de Alava, José Antonio, López García-Asenjo, María Dolores, Guitián, Sergio, Almenar, Jesús Fernando, González-Palacios, Francisco, Vera, José, Palacios, Manuel, Ramos, Jose Manuel, Gracia Marco, Ana, Lluch, Isabel, Alvarez, Miguel Angel, Seguí, José Ignacio, Mayordomo, Antonio, Antón, José Manuel, Baena, Arrate, Plazaola, Alfonso, Modolell, Amadeu, Pelegrí, Jose Ramón, Mel, Enrique, Aranda, Encarna, Adrover, José Valero, Alvarez, José Luis, García Puche, Pedro, Sánchez-Rovira, Sonia, Gonzalez, José Manuel, López-Vega, M Francisca, Garijo

المساهمون: GEICAM 9906 Study Investigators, [Martín,M] Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain. [López García-Asenjo,JA] Department of Pathology, Hospital Universitario San Carlos, Madrid, Spain. [Rodríguez-Lescure,A] Department of Medical Oncology, Hospital Universitario de Elche, Spain. [Ruiz,A] Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain. [Almenar,S] Department of Pathology, Instituto Valenciano de Oncologia, Valencia, Spain. [Alba Conejo,E] Department of Medical Oncology, Hospital Virgen de la Victoria, Málaga, Spain. [Calvo,L] Department of Medical Oncology, Complejo Hospitalario Juan Canalejo, La Coruña, Spain. [Guitián,MD] Department of Pathology, Complejo Hospitalario Juan Canalejo, La Coruña, Spain. [Ruiz-Borrego,M] Department of Medical Oncology, Hospital Vírgen del Rocío, Sevilla, Spain [Palacios,J] Department of Pathology, Hospital Vírgen del Rocío, Sevilla, Spain. [Muñárriz,B] Department of Medical Oncology, Hospital La Fe, Valencia, Spain. [Vera,F] Department of Pathology, Hospital La Fe, Valencia, Spain. [Rodríguez, CA] Department of Medical Oncology, Hospital Universitario de Salamanca, Salamanca, Spain. [Crespo,C] Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. [González-Palacios,JF] Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain. [de Álava,E] Department of Pathology, Centro de Investigación del Cáncer, Salamanca, Spain. [Ramos,M] Department of Medical Oncology, Centro Oncológico de Galicia, La Coruña, Spain. [Gracia Marco,JM] Department of Medical Oncology, Hospital de Cabueñes, Gijón, Spain. [Lluch,A] Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain. [Álvarez,I] Department of Medical Oncology, Hospital de Donostia, San Sebastián, Spain. [Seguí,MA] Department of Medical Oncology, Hospital Parc Taulí, Sabadell, Spain. [Mayordomo,JI] Department of Medical Oncology, Hospital Clínico Lozano Blesa, Zaragoza, Spain. [Antón,A] Department of Medical Oncology, Hospital Miguel Servet, Zaragoza, Spain. [Baena,JM] Department of Medical Oncology, Complejo Hospitalario Puerta del Mar, Cádiz, Spain. [Plazaola,A] Department of Medical Oncology, Instituto Oncológico de Guipúzcoa, San Sebastián, Spain. [Modolell,A] Department of Medical Oncology, Clínica Corachan, Barcelona, Spain. [Pelegrí,A] Department of Medical Oncology, Hospital Universitario San Joan de Reus, Tarragona, Spain. [Mel,JR] Department of Medical Oncology, Complejo Hospitalario Xeral Calde, Lugo, Spain. [Aranda,E] Department of Medical Oncology, Hospital Provincial de Córdoba, Córdoba, Spain. [Adrover,E] Department of Medical Oncology, Hospital General de Alicante, Alicante, Spain. [Valero Álvarez,J] Hospital Provincial de Zamora, Spain. [García Puche,JL] Department of Medical Oncology, Hospital San Cecilio de Granada, Granada, Spain. [Sánchez-Rovira,P] Department of Medical Oncology, Hospital Ciudad de Jaén, Jaén, Spain. [González,S] Department of Medical Oncology, Mutua de Terrasa, Terrasa, Spain. [López-Vega,JM] Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Department of Medical Oncology, Hospital Ciudad de Jaén, Jaén, Spain

المصدر: JNCI Journal of the National Cancer Institute. 100:805-814

مصطلحات موضوعية: Oncology, medicine.medical_treatment, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Supervivencia sin Enfermedad, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2 [Medical Subject Headings], Antineoplastic Combined Chemotherapy Protocols, Estimación de Kaplan-Meier, Receptor erbB-2, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule [Medical Subject Headings], Hazard ratio, Pronóstico, Epirrubicina, Prognosis, Immunohistochemistry, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Carcinoma, Ductal::Carcinoma, Ductal, Breast [Medical Subject Headings], Receptors, Estrogen, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Neoplasm Staging [Medical Subject Headings], Chemicals and Drugs::Biological Factors::Biological Markers::Tumor Markers, Biological [Medical Subject Headings], Receptors, Progesterone, Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Alicyclic::Cycloparaffins::Cyclodecanes::Taxoids::Paclitaxel [Medical Subject Headings], medicine.medical_specialty, Paclitaxel, Fluorouracilo, Axillary lymph nodes, Resultado del Tratamiento, Anciano, Disease-Free Survival, Drug Administration Schedule, Breast cancer, Carcinoma Lobular, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Adjuvant therapy, Humans, Cyclophosphamide, Aged, ERBB2 protein, human, medicine.disease, Carcinoma, Lobular, Check Tags::Female [Medical Subject Headings], Modelos de Riesgos Proporcionales, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Histocytological Preparation Techniques::Staining and Labeling::In Situ Hybridization::In Situ Hybridization, Fluorescence [Medical Subject Headings], Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis::Disease-Free Survival [Medical Subject Headings], Cancer Research, Receptor, ErbB-2, Kaplan-Meier Estimate, Antineoplásicos Fitogénicos, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Carcinoma, Lobular [Medical Subject Headings], Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrimidines::Pyrimidinones::Uracil::Fluorouracil [Medical Subject Headings], Infusions, Intravenous, In Situ Hybridization, Fluorescence, Carcinoma, Ductal, Breast, Neoplasias de la Mama, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Estrogen [Medical Subject Headings], Middle Aged, Chemotherapy regimen, Treatment Outcome, medicine.anatomical_structure, Female, Fluorouracil, Breast disease, Infusiones Intravenosas, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Phytogenic [Medical Subject Headings], Epirubicin, medicine.drug, Adult, Protocolos de Quimioterapia Combinada Antineoplásica, Hibridación Fluorescente In Situ, Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Halogenated::Mustard Compounds::Nitrogen Mustard Compounds::Phosphoramide Mustards::Cyclophosphamide [Medical Subject Headings], Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::DNA-Binding Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Progesterone [Medical Subject Headings], Breast Neoplasms, Ciclofosfamida, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Models, Statistical::Proportional Hazards Models [Medical Subject Headings], Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biochemistry::Immunochemistry [Medical Subject Headings], Predictive Value of Tests, Internal medicine, Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Doxorubicin::Epirubicin [Medical Subject Headings], Biomarkers, Tumor, medicine, Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings], Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings], Neoplasm Staging, Proportional Hazards Models, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings], Receptores de Progesterona, Chemotherapy, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Kaplan-Meier Estimate [Medical Subject Headings], business.industry, Esquema de Medicación, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Routes::Infusions, Parenteral::Infusions, Intravenous [Medical Subject Headings], Antineoplastic Agents, Phytogenic, Estadificación de Neoplasias, Receptores Estrogénicos, Surgery, Marcadores Biológicos de Tumor, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings], business, Carcinoma Ductal de Mama, Inmunohistoquímica

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231d70f647e63977f91a08e2c0626e55
https://doi.org/10.1093/jnci/djn151

المؤلفون: A. Millet, E. Torres, F. Escobar-Jiménez, E. López, Joaquim Calaf, Fortuny A, Juan José Espinós, Justo Callejo, J. Alcañiz, O. Vidal

المساهمون: Spanish Working Group for Hirsutism, [Calaf, J, Espinos, JJ] Department of Gynaecology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [López, E] Department of Gynaecology, Hospital Virgen de la Arrixaca, Murcia, Spain. [Millet, A] Department of Gynaecology, Hospital Clínico Universitario de Valencia, Valencia, Spain. [Alcaniz, J] Department of Endocrinology), Clínica Puerta de Hierro,28035 Madrid, Spain. [Fortuny, A] Department of Gynaecology, Hospital Clıinic i Provincial de Barcelona, 08036 Barcelona,Spain. [Vidal, O] Department of Endocrinology, Hospital Juan Canalejo, 15006 La Coruña, Spain. [Callejo, J] Department of Gynaecology, Hospital San Joan de Déu, 08950 Barcelona, Spain. [Escobar-Jiménez,F, Torres, E] Department of Endocrinology, Hospital Clínico de Granada, Granada, Spain, The study has been sponsored by Ipsen Pharma, S.A., Barcelona, Spain.

المصدر: The Journal of Clinical Endocrinology & Metabolism. 92:3446-3452

مصطلحات موضوعية: Hirsutism, Time Factors, Phenomena and Processes::Physical Phenomena::Time::Time Factors [Medical Subject Headings], Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Antiandrogen, Biochemistry, Flutamide, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Placebos, chemistry.chemical_compound, Endocrinology, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Reproductive Control Agents::Contraceptive Agents::Contraceptive Agents, Female::Contraceptives, Oral::Contraceptives, Oral, Hormonal [Medical Subject Headings], Acné Vulgar, Acne Vulgaris, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Placebos [Medical Subject Headings], Anticonceptivos Hormonales Orales, Levonorgestrel, Chemicals and Drugs::Organic Chemicals::Amides::Anilides::Flutamide [Medical Subject Headings], Adolescente, hirsutism, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule [Medical Subject Headings], education.field_of_study, Adulto, Quimioterapia Combinada, Femenino, Antagonistas de Andrógenos, Polycystic ovary, Humanos, Treatment Outcome, Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Androgen Antagonists [Medical Subject Headings], Tolerability, Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings], Drug Therapy, Combination, Female, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Oral contraceptive pill, Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Dermatitis::Dermatitis, Seborrheic [Medical Subject Headings], medicine.drug_class, Resultado del Tratamiento, Population, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination [Medical Subject Headings], Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Virilism::Hirsutism [Medical Subject Headings], Drug Administration Schedule, Contraceptives, Oral, Hormonal, Dermatitis Seborreica, Double-Blind Method, Internal medicine, Método Doble Ciego, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], medicine, Humans, Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Acneiform Eruptions::Acne Vulgaris [Medical Subject Headings], Relación Dosis-Respuesta a Droga, education, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings], Dose-Response Relationship, Drug, business.industry, Esquema de Medicación, Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Dose-Response Relationship, Drug [Medical Subject Headings], Biochemistry (medical), Androgen Antagonists, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Methods::Research Design::Double-Blind Method [Medical Subject Headings], medicine.disease, Dermatitis, Seborrheic, Flutamida, Check Tags::Female [Medical Subject Headings], chemistry, Hirsutismo, business, Factores de Tiempo

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccd52bd1ea254d307897ccad9727b7d3
https://doi.org/10.1210/jc.2006-2798

المؤلفون: F. Navarro-Sarabia, Mireia Barceló, Eva Perez-Pampin, Victoria Navarro-Compán, Juan J. Gomez-Reino, Blanca Hernández, Sara Marsal, Dolores Ruiz-Montesinos

المساهمون: Universidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina, [Navarro-Sarabia,F, Ruiz-Montesinos,D, Hernandez,B, Navarro-Compán,V] Rheumatology Service, Hospital Universitario Virgen Macarena, Sevilla, Spain. [Marsal,S, Barcelo,M] Rheumatology Service, Hospital Universitario Vall d'Hebron, Barcelona, Spain. [Perez-Pampín,E, Gómez-Reino,JJ] Rheumatology Service, Hospital Clínico de Santiago and Department of Medicine, USC, Santiago, Spain., The study was partially funded by a grant of BMS, Spain, and by RETICS Program,RD08/0075 (RIER) from the Instituto de Salud Carlos III (ISCIII),within the VI PN de I+D+I 2008–2011.

المصدر: Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
BMC Musculoskeletal Disorders, Vol 10, Iss 1, p 91 (2009)
BMC Musculoskeletal Disorders

مصطلحات موضوعية: Male, Time Factors, lcsh:Diseases of the musculoskeletal system, Phenomena and Processes::Physical Phenomena::Time::Time Factors [Medical Subject Headings], Arthritis, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome::Treatment Failure [Medical Subject Headings], Gastroenterology, Arthritis, Rheumatoid, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, Esquema de medicación, Surveys and Questionnaires, Tumor necrosis factor-alpha, Orthopedics and Sports Medicine, Prospective Studies, Treatment Failure, Cuestionarios, Prospective cohort study, Insuficiencia del tratamiento, Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule [Medical Subject Headings], Middle Aged, Tocilizumab, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Monokines::Tumor Necrosis Factor-alpha [Medical Subject Headings], Antirreumáticos, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Sensitivity and Specificity::Predictive Value of Tests [Medical Subject Headings], Databases as Topic, Antirheumatic Agents, Rheumatoid arthritis, Predictive value of tests, Cohort, Female, Research Article, medicine.drug, Adult, medicine.medical_specialty, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies [Medical Subject Headings], Information Science::Information Science::Information Storage and Retrieval::Databases as Topic [Medical Subject Headings], Check Tags::Male [Medical Subject Headings], Artritis reumatoide, Herpes Zoster, Retention Rate, Drug Administration Schedule, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antirheumatic Agents [Medical Subject Headings], Information Science::Information Science::Data Collection::Questionnaires [Medical Subject Headings], Abatacept, Valor predictivo de las pruebas, Rheumatology, Predictive Value of Tests, Internal medicine, Diseases::Musculoskeletal Diseases::Joint Diseases::Arthritis::Arthritis, Rheumatoid [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], medicine, Humans, Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings], Aged, Tumor Necrosis Factor-alpha, business.industry, medicine.disease, Factor de necrosis tumoral alfa, Surgery, Rheumatoid Arthritis Patient, Bases de datos como asunto, Check Tags::Female [Medical Subject Headings], chemistry, Spain, lcsh:RC925-935, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8548983e7679bf37162b3d8a33befe
http://hdl.handle.net/10347/22952

المؤلفون: R. Garcia-Juárez, José A. Girón-González, C. Fernández Gutiérrez del Álamo, M. Montes de Oca Arjona, Andrés Martín-Aspas, R. Pérez-Cano

المساهمون: [Montes de Oca-Arjona, M, Pérez-Cano, R, García-Juarez, R, Martín-Aspas, A, Girón-Gonzáez, JA] Internal Medicine Services, Hospital Universitario Puerta del Mar, Cádiz, Spain. [Fernández-Gutiérrez del Álamo, C] Microbiology Services, Hospital Universitario Puerta del Mar, Cádiz, Spain.

مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Male, Leptin, HIV Infections, Gastroenterology, Anatomy::Hemic and Immune Systems::Blood::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::CD4-Positive T-Lymphocytes [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Tumor Necrosis Factors::Tumor Necrosis Factor-alpha [Medical Subject Headings], Immunopathology, Antiretroviral Therapy, Highly Active, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic::Receptors, Cytokine::Receptors, Tumor Necrosis Factor::Receptors, Tumor Necrosis Factor, Type II [Medical Subject Headings], Factor de Necrosis Tumoral alfa, Sida, Chemicals and Drugs::Lipids::Glycerides::Triglycerides [Medical Subject Headings], Phenomena and Processes::Microbiological Phenomena::Virus Physiological Phenomena::Viral Load [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule [Medical Subject Headings], Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Chronic Disease [Medical Subject Headings], biology, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination::Antiretroviral Therapy, Highly Active [Medical Subject Headings], Estudios de Casos y Controles, Chemicals and Drugs::Polycyclic Compounds::Steroids::Cholestanes::Cholestenes::Cholesterol [Medical Subject Headings], Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Skinfold Thickness [Medical Subject Headings], Reference Standards, Viral Load, Grosor de Pliegues Cutáneo, Skinfold Thickness, Infectious Diseases, medicine.anatomical_structure, Treatment Outcome, Cholesterol, Receptors, Tumor Necrosis Factor, Type I, RNA, Viral, Receptors, Leptin, Female, Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections [Medical Subject Headings], Viral disease, Viral load, Colesterol, Adult, medicine.medical_specialty, T cell, Receptores Tipo II del Factor de Necrosis Tumoral, Immunology, Adipokine, Check Tags::Male [Medical Subject Headings], Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Adipokine::Receptors, Leptin [Medical Subject Headings], Drug Administration Schedule, Triglicéridos, Receptores de Leptina, Acquired immunodeficiency syndrome (AIDS), Leptina, Virology, Internal medicine, medicine, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Humans, Receptors, Tumor Necrosis Factor, Type II, Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA::RNA, Viral [Medical Subject Headings], Receptores Tipo I de Factores de Necrosis Tumoral, Triglycerides, Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Adipokines::Leptin [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings], Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], business.industry, Tumor Necrosis Factor-alpha, Enfermedad crónica, Leptin receptor, human, Linfocitos T CD4-Positivos, Recuento de Linfocito CD4, biology.organism_classification, medicine.disease, CD4 Lymphocyte Count, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Clinical Laboratory Techniques::Cytological Techniques::Cell Count::Blood Cell Count::Leukocyte Count::Lymphocyte Count::CD4 Lymphocyte Count [Medical Subject Headings], Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, CD::Receptors, Tumor Necrosis Factor, Type II [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Weights and Measures::Reference Standards [Medical Subject Headings], Check Tags::Female [Medical Subject Headings], Case-Control Studies, Chronic Disease, HIV-1, Receptores de leptina, humanos, business, ARN Viral

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43771a1c90749b4dc8ddb4ea5a16a1ab
https://hdl.handle.net/10668/696

المؤلفون: Luis Paz-Ares, Antonio Rueda, Carlos Lage Gómez, Carlos Lumbreras, Jose Luis Perez-Gracia, Hernán Cortés-Funes, A. Yubero, María Victoria Tornamira, Marta López-Brea, Alberto Arcediano, Rocio Garcia-Carbonero, Vicente Guillem, Alejandro Tres, Javier Hornedo, Fernando Ribera, Jose I. Mayordomo

المساهمون: [García-Carbonero,R, Tornamira,MV, Arcediano,A, Gómez,C, Pérez-Gracia,JL, Hornedo,J, Cortés-Funes,H, Paz-Ares,L] Division of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. [Mayordomo,JI, Yubero,A, Trés,A] Division of Medical Oncology, Hospital Clínico, Zaragoza, Spain. [López-Brea,M, Rivera,F] Division of Medical Oncology, Hospital M. Valdecilla, Santander, Spain. [Rueda Domínguez,A] Division of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Guillém,V] Division of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain. [Lumbreras,C] Division of Infectious Diseases, Hospital Universitario Doce de Octubre, Madrid, Spain.

المصدر: Scopus-Elsevier

مصطلحات موضوعية: Male, Cancer Research, Time Factors, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Proportional Hazards Models [Medical Subject Headings], Phenomena and Processes::Physical Phenomena::Time::Time Factors [Medical Subject Headings], Cost-Benefit Analysis, España, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Hematopoietic Cell Growth Factors::Colony-Stimulating Factors::Granulocyte Colony-Stimulating Factor [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Body Temperature Changes::Fever [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Medicine, Prospective Studies, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [Medical Subject Headings], Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule [Medical Subject Headings], Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis [Medical Subject Headings], Leukopenia, Diseases::Neoplasms [Medical Subject Headings], Middle Aged, Chemotherapy regimen, Neoplasias, Granulocyte colony-stimulating factor, Anti-Bacterial Agents, Treatment Outcome, Antibacterianos, Oncology, Amikacin, Absolute neutrophil count, Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Agranulocytosis::Neutropenia [Medical Subject Headings], Female, medicine.symptom, Análisis Costo-Beneficio, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings], medicine.drug, Protocolos de Quimioterapia Combinada Antineoplásica, medicine.medical_specialty, Neutropenia, Fever, Análisis de Supervivencia, Resultado del Tratamiento, Check Tags::Male [Medical Subject Headings], Drug Administration Schedule, Health Care::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis [Medical Subject Headings], Internal medicine, Humans, Health Care::Health Care Facilities, Manpower, and Services::Health Services::Patient Care::Hospitalization::Length of Stay [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings], Aged, Proportional Hazards Models, Performance status, business.industry, Esquema de Medicación, Length of Stay, medicine.disease, Survival Analysis, Surgery, Factor Estimulante de Colonias de Granulocitos, Check Tags::Female [Medical Subject Headings], Spain, Health Care::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome [Medical Subject Headings], Modelos de Riesgos Proporcionales, business, Fiebre, Factores de Tiempo, Febrile neutropenia, Tiempo de Internación

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe6e8098b0d7b1788f3f6b5647ab97d
http://www.scopus.com/inward/record.url?eid=2-s2.0-0035798795&partnerID=MN8TOARS